[
    [
        {
            "time": "",
            "original_text": "国泰君安(02611.HK)控股股东及一致行动人减持700万张A股可转债 减持股份",
            "features": {
                "keywords": [
                    "国泰君安",
                    "控股股东",
                    "一致行动人",
                    "减持",
                    "可转债"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国泰君安(02611.HK)控股股东及一致行动人减持700万张A股可转债 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "国泰君安：控股股东及一致行动人合计减持可转债700万张，占发行总量的10%",
            "features": {
                "keywords": [
                    "国泰君安",
                    "控股股东",
                    "一致行动人",
                    "减持",
                    "可转债",
                    "发行总量"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国泰君安：控股股东及一致行动人合计减持可转债700万张，占发行总量的10%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "108股获券商买入评级 天康生物目标涨幅达71.88%",
            "features": {
                "keywords": [
                    "券商",
                    "买入评级",
                    "天康生物",
                    "目标涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "农业",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "108股获券商买入评级 天康生物目标涨幅达71.88%",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]